• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于动态对比增强磁共振成像结果的药代动力学分析预测和监测口腔鳞状细胞癌对放化疗的反应。

Prediction and monitoring of the response to chemoradiotherapy in oral squamous cell carcinomas using a pharmacokinetic analysis based on the dynamic contrast-enhanced MR imaging findings.

机构信息

Department of Oral and Maxillofacial Radiology, Faculty of Dental Science, Kyushu University, Maidashi 3-1-1, Higashi-ku, Fukuoka 812-8582, Japan.

出版信息

Eur Radiol. 2011 Aug;21(8):1699-708. doi: 10.1007/s00330-011-2102-x. Epub 2011 Mar 12.

DOI:10.1007/s00330-011-2102-x
PMID:21394565
Abstract

OBJECTIVES

To evaluate whether a pharmacokinetic analysis is useful for both predicting and monitoring the response to chemoradiotherapy (CRT) in oral cancer.

METHODS

Patients with oral squamous cell carcinoma treated with preoperative CRT and surgery were enrolled. They underwent dynamic contrast-enhanced MRI before (n = 23), and after CRT (n = 20). We estimated four parameters: arrival time of contrast medium (TA), exchange rate constant from the extracellular extravascular space (EES) to plasma (k(ep)), elimination of contrast medium from the central compartment (k(el)) and an amplitude scaling constant (AH) using the Brix model. The histological evaluation of the effects of CRT was performed according to Ohboshi and Shimosato's classification. We analysed the correlation between the parameters and the histological evaluation.

RESULTS

The pre-CRT AH between the responders and non-responders was significantly different (P = 0.046), however, the three parameters (TA, K(ep), K(el)) were not significantly different among the groups (P = 0.76, P = 0.60, P = 0.09). As AH decreased, the tumour response improved. The change in the AH between the pre- and post-CRT of responders was significantly higher than that of non-responders (P = 0.043).

CONCLUSION

The AH, which is affected by the ratio of the EES, was an important parameter for predicting and monitoring the tumour response to CRT.

摘要

目的

评估药代动力学分析是否有助于预测和监测口腔癌放化疗(CRT)的反应。

方法

纳入接受术前 CRT 和手术治疗的口腔鳞状细胞癌患者。他们在 CRT 前(n=23)和 CRT 后(n=20)进行了动态对比增强 MRI。我们使用 Brix 模型估计了四个参数:对比剂到达时间(TA)、从细胞外细胞外空间(EES)到血浆的交换率常数(k(ep))、中央隔室对比剂的消除(k(el))和幅度缩放常数(AH)。根据 Ohboshi 和 Shimosato 的分类对 CRT 的组织学效应进行评估。我们分析了参数与组织学评估之间的相关性。

结果

应答者和无应答者之间的 CRT 前 AH 差异具有统计学意义(P=0.046),而三组间的 TA、K(ep)和 K(el)参数均无统计学差异(P=0.76、P=0.60、P=0.09)。随着 AH 的降低,肿瘤的反应性提高。应答者 CRT 前后 AH 的变化明显高于无应答者(P=0.043)。

结论

AH 受 EES 比例的影响,是预测和监测 CRT 肿瘤反应的重要参数。

相似文献

1
Prediction and monitoring of the response to chemoradiotherapy in oral squamous cell carcinomas using a pharmacokinetic analysis based on the dynamic contrast-enhanced MR imaging findings.基于动态对比增强磁共振成像结果的药代动力学分析预测和监测口腔鳞状细胞癌对放化疗的反应。
Eur Radiol. 2011 Aug;21(8):1699-708. doi: 10.1007/s00330-011-2102-x. Epub 2011 Mar 12.
2
Pharmacokinetic analysis based on dynamic contrast-enhanced MRI for evaluating tumor response to preoperative therapy for oral cancer.基于动态对比增强 MRI 的药代动力学分析评估口腔癌术前治疗的肿瘤反应。
J Magn Reson Imaging. 2012 Sep;36(3):589-97. doi: 10.1002/jmri.23704. Epub 2012 May 30.
3
Histogram analysis of DCE-MRI for chemoradiotherapy response evaluation in locally advanced esophageal squamous cell carcinoma.DCE-MRI 直方图分析在局部晚期食管鳞癌放化疗疗效评估中的应用。
Radiol Med. 2020 Feb;125(2):165-176. doi: 10.1007/s11547-019-01081-1. Epub 2019 Oct 11.
4
Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome.从宫颈癌动态对比增强 MRI 得出的药代动力学参数可预测放化疗结果。
Radiother Oncol. 2013 Apr;107(1):117-22. doi: 10.1016/j.radonc.2012.11.007. Epub 2013 Jan 17.
5
Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.3T磁共振成像动态对比增强扫描在前列腺癌中的应用:药代动力学参数研究
AJR Am J Roentgenol. 2007 Oct;189(4):849. doi: 10.2214/AJR.06.1329.
6
Dynamic contrast-enhanced MRI histogram parameters predict progression-free survival in patients with advanced esophageal squamous carcinoma receiving concurrent chemoradiotherapy.动态对比增强磁共振成像直方图参数可预测接受同步放化疗的晚期食管鳞癌患者的无进展生存期。
Acta Radiol. 2020 Oct;61(10):1316-1325. doi: 10.1177/0284185120903139. Epub 2020 Feb 13.
7
Comparing the Performances of Magnetic Resonance Imaging Size vs Pharmacokinetic Parameters to Predict Response to Neoadjuvant Chemotherapy and Survival in Patients With Breast Cancer.比较磁共振成像大小与药代动力学参数预测乳腺癌患者新辅助化疗反应及生存情况的性能
Curr Probl Diagn Radiol. 2019 May-Jun;48(3):235-240. doi: 10.1067/j.cpradiol.2018.03.003. Epub 2018 Mar 28.
8
Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.半定量和定量动态对比增强磁共振成像测量可预测宫颈癌的放射反应。
Int J Radiat Oncol Biol Phys. 2009 Jul 1;74(3):766-73. doi: 10.1016/j.ijrobp.2008.08.023. Epub 2008 Nov 18.
9
Assessment of tumor microcirculation with dynamic contrast-enhanced MRI in patients with esophageal cancer: initial experience.动态对比增强磁共振成像评估食管癌患者的肿瘤微循环:初步经验
J Magn Reson Imaging. 2008 Jun;27(6):1296-301. doi: 10.1002/jmri.21305.
10
Utility of intravoxel incoherent motion diffusion-weighted imaging in predicting early response to concurrent chemoradiotherapy in oesophageal squamous cell carcinoma.IVIM-DWI 在预测食管鳞癌同期放化疗早期疗效中的应用。
Clin Radiol. 2018 Aug;73(8):756.e17-756.e26. doi: 10.1016/j.crad.2018.03.015. Epub 2018 May 3.

引用本文的文献

1
Dynamic contrast enhanced MRI of pulmonary adenocarcinomas for early risk stratification: higher contrast uptake associated with response and better prognosis.动态对比增强 MRI 对肺腺癌的早期风险分层:较高的对比摄取与反应和更好的预后相关。
BMC Med Imaging. 2022 Dec 5;22(1):215. doi: 10.1186/s12880-022-00943-x.
2
Dynamic contrast-enhanced magnetic resonance imaging for evaluating early response to radiosurgery in patients with vestibular schwannoma.动态对比增强磁共振成像评估听神经鞘瘤患者放射外科治疗早期反应。
Jpn J Radiol. 2022 Jul;40(7):678-688. doi: 10.1007/s11604-021-01245-y. Epub 2022 Jan 17.
3
Dynamic Contrast-Enhanced MR Imaging in Head and Neck Cancer: Techniques and Clinical Applications.

本文引用的文献

1
Pretreatment apparent diffusion coefficient of the primary lesion correlates with local failure in head-and-neck cancer treated with chemoradiotherapy or radiotherapy.原发肿瘤的预处理表观扩散系数与头颈部癌患者接受放化疗或单纯放疗后的局部失败相关。
Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):339-45. doi: 10.1016/j.ijrobp.2010.05.051. Epub 2010 Sep 9.
2
Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response.头颈部鳞状细胞癌:扩散加权磁共振成像预测和监测治疗反应。
Eur Radiol. 2010 Sep;20(9):2213-20. doi: 10.1007/s00330-010-1769-8. Epub 2010 Mar 23.
3
头颈部癌的动态对比增强磁共振成像:技术与临床应用
AJNR Am J Neuroradiol. 2016 Apr;37(4):588-95. doi: 10.3174/ajnr.A4458. Epub 2015 Oct 1.
4
Dynamic contrast-enhanced MRI of oral squamous cell carcinoma: a preliminary study of the correlations between quantitative parameters and the clinical stage.口腔鳞状细胞癌的动态对比增强磁共振成像:定量参数与临床分期相关性的初步研究
Br J Radiol. 2015 Jun;88(1050):20140814. doi: 10.1259/bjr.20140814. Epub 2015 Apr 23.
5
Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer.头颈部鳞状细胞癌成像的当前肿瘤学概念与新兴技术
GMS Curr Top Otorhinolaryngol Head Neck Surg. 2012;11:Doc08. doi: 10.3205/cto000090. Epub 2012 Dec 20.
6
The principal of dynamic contrast enhanced MRI, the method of pharmacokinetic analysis, and its application in the head and neck region.动态对比增强磁共振成像原理、药代动力学分析方法及其在头颈部区域的应用。
Int J Dent. 2012;2012:480659. doi: 10.1155/2012/480659. Epub 2012 Oct 18.
Predictive value of diffusion-weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma.
磁共振弥散加权成像在头颈部鳞癌放化疗中的预测价值。
Eur Radiol. 2010 Jul;20(7):1703-14. doi: 10.1007/s00330-010-1734-6. Epub 2010 Feb 24.
4
Chemoradiation for patients with advanced oral cavity cancer.晚期口腔癌患者的放化疗。
Laryngoscope. 2010 Jan;120(1):93-9. doi: 10.1002/lary.20716.
5
Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.利用动态对比增强磁共振成像预测头颈部鳞状细胞癌的放化疗反应。
AJNR Am J Neuroradiol. 2010 Feb;31(2):262-8. doi: 10.3174/ajnr.A1817. Epub 2009 Oct 1.
6
Perfusion characteristics of late radiation injury of parotid glands: quantitative evaluation with dynamic contrast-enhanced MRI.腮腺晚期放射性损伤的灌注特征:动态对比增强MRI定量评估
Eur Radiol. 2009 Jan;19(1):94-102. doi: 10.1007/s00330-008-1104-9. Epub 2008 Jul 26.
7
Head and neck squamous cell carcinoma: usefulness of diffusion-weighted MR imaging in the prediction of a neoadjuvant therapeutic effect.头颈部鳞状细胞癌:扩散加权磁共振成像在预测新辅助治疗效果中的应用价值
Eur Radiol. 2009 Jan;19(1):103-9. doi: 10.1007/s00330-008-1108-5. Epub 2008 Jul 19.
8
Assessment of tumor microcirculation with dynamic contrast-enhanced MRI in patients with esophageal cancer: initial experience.动态对比增强磁共振成像评估食管癌患者的肿瘤微循环:初步经验
J Magn Reson Imaging. 2008 Jun;27(6):1296-301. doi: 10.1002/jmri.21305.
9
Quantitative dynamic contrast-enhanced MRI for the assessment of mandibular invasion by squamous cell carcinoma.用于评估鳞状细胞癌下颌骨侵犯的定量动态对比增强磁共振成像
Oral Oncol. 2008 Dec;44(12):1147-54. doi: 10.1016/j.oraloncology.2008.02.009. Epub 2008 May 16.
10
Glandular function in Sjögren syndrome: assessment with dynamic contrast-enhanced MR imaging and tracer kinetic modeling--initial experience.
Radiology. 2008 Mar;246(3):845-53. doi: 10.1148/radiol.2463070298. Epub 2008 Jan 30.